www.benzinga.com
Open in
urlscan Pro
151.101.66.137
Public Scan
URL:
https://www.benzinga.com/news/24/08/40155773/ascendiant-capital-initiates-coverage-on-mira-pharmaceuticals-with-buy-ratin...
Submission: On August 05 via api from BE — Scanned from DE
Submission: On August 05 via api from BE — Scanned from DE
Form analysis
0 forms found in the DOMText Content
THE ONLY MONTHLY MEMBERSHIP WITH A POSITIVE ROI! * Get Benzinga Pro * Data & APIs * Events * Marketfy * Premarket * Boost * Advertise Contribute España India Italia 대한민국 日本 LoginRegister * Our Services * News Earnings Guidance Dividends M&A Buybacks Legal Interviews Management Offerings IPOs Insider Trades Biotech/FDA Politics Government Healthcare * Markets Pre-Market After Hours Movers ETFs Forex Cannabis Commodities Binary Options Bonds Futures CME Group Global Economics Mining Previews Small-Cap Real Estate Cryptocurrency Penny Stocks Digital Securities Volatility * Options * Ratings Analyst Color Downgrades Upgrades Initiations Price Target * Ideas Trade Ideas Long Ideas Short Ideas Technicals From The Press Jim Cramer Rumors Stock of the Day Best Stocks & ETFs Best Penny Stocks Best S&P 500 ETFs Best Swing Trade Stocks Best Blue Chip Stocks Best High-Volume Penny Stocks Best Small Cap ETFs Best Stocks to Day Trade Best REITs * Money Investing Cryptocurrency Mortgage Insurance Yield Personal Finance Forex Startup Investing Real Estate Investing Prop Trading Credit Cards * Crypto * Cannabis Cannabis Conference News Earnings Interviews Deals Regulations Psychedelics * Jobs Options Ratings Analyst Color Downgrades Upgrades Initiations Price Target Ideas Trade Ideas Long Ideas Short Ideas Technicals From The Press Jim Cramer Rumors Stock of the Day Best Stocks & ETFs Best Penny Stocks Best S&P 500 ETFs Best Swing Trade Stocks Best Blue Chip Stocks Best High-Volume Penny Stocks Best Small Cap ETFs Best Stocks to Day Trade Best REITs Money Investing Cryptocurrency Mortgage Insurance Yield Personal Finance Forex Startup Investing Real Estate Investing Prop Trading Credit Cards Crypto Cannabis Cannabis Conference News Earnings Interviews Deals Regulations Psychedelics Jobs Research My Stocks Tools Free Benzinga Pro Trial Calendars Analyst Ratings Calendar Conference Call Calendar Dividend Calendar Earnings Calendar Economic Calendar FDA Calendar Guidance Calendar IPO Calendar M&A Calendar SPAC Calendar Stock Split Calendar Trade Ideas Free Stock Reports Insider Trades Trade Idea Feed Analyst Ratings Unusual Options Activity Heatmaps Free Newsletter Government Trades Short Interest Most Shorted Largest Increase Largest Decrease Calculators Margin Calculator Forex Profit Calculator 100x Options Profit Calculator RecentMarkets SPY 511.823.96% QQQ 424.785.34% SPIKE 23.51- BTC/USD 51353.5811.7758% DIA 386.532.67% GLD 220.632.09% TLT 99.691.43% ASCENDIANT CAPITAL INITIATES COVERAGE ON MIRA... by Benzinga News Desk August 5, 2024 6:16 AM | 18 seconds read | Make a Comment Never miss a trade again with the fastest news alerts in the world! This headline only article is a sample of real-time intelligence Benzinga Pro traders use to win in the markets everyday. Want the fastest, most accurate stock market intelligence? Want EXCLUSIVE stories originated by Benzinga reporters? Join 10,000+ serious traders in the Benzinga Pro community! * The most trusted brand in stock market news * Fatest intelligence & alerts * Active trader chat rooms * Option trade alerts * Only comprehensive mobile notifications solution * Welcoming & white glove support Active My Free Trial Be the first to comment! COMMENTS Close menu Loading... EarningsAnalyst RatingsOptionsDividendsIPOs date ▲▼ ticker ▲▼ name ▲▼ Price Target ▲▼ Upside/Downside ▲▼ Recommendation ▲▼ Firm ▲▼ 08/05/2024 MIRA Mira Pharmaceuticals → $11— → BuyAscendiant Capital Click to see more Analyst Ratings updates Posted In: NewsPrice TargetInitiationAnalyst Ratings Benzinga simplifies the market for smarter investing Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about. Join Now: Free! Already a member?Sign in -------------------------------------------------------------------------------- SCILEX HOLDING COMPANY PROVIDES CERTAIN PRELIMINARY UNAUDITED FINANCIAL RESULTS FOR THE MONTH ENDED JULY 31, 2024 by Scilex Holding Company August 1, 2024 2:48 PM | 6 min read | Make a Comment Partner Disclosure PALO ALTO, CALIFORNIA – August 1, 2024 (GLOBE NEWSWIRE) – Scilex Holding Company SCLX "Scilex" or the "Company"), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, today provided certain preliminary unaudited financial results for the month ended July 31, 2024. Scilex generates continuous sales growth in ZTlido® going into third quarter of 2024 with preliminary net sales for ZTlido® in the range of $4.0 million to $5.0 million. The Company estimates that: This preliminary financial data has been prepared by and is the responsibility of Scilex. Scilex has not fully completed its review of these preliminary financial results for the month ended July 31, 2024. Scilex's independent auditor has not reviewed or audited these preliminary estimated financial results. Scilex's actual results may differ materially from these preliminary financial results and may be outside the estimated ranges For more information on Scilex Holding Company, refer to www.scilexholding.co For more information on ZTlido® including Full Prescribing Information, refer to www.ztlido.co Read More -------------------------------------------------------------------------------- BLOODBATH IN ASIA AND EUROPE, JAPAN'S INDEX CRASHES 13%; GOLD NEAR RECORD HIGHS - GLOBAL MARKETS UPDATE WHILE US SLEPT by Akanksha Bakshi, Benzinga Editor August 5, 2024 6:44 AM | 3 min read | 1 Comment ZINGER KEY POINTS * Japan’s Nikkei 225 closed drastically lower by 13.47% ending the session at 31,078.00. * Crude Oil WTI traded lower by 1.97% at $72.09/bbl, and Brent was down 1.79% at $75.45 bbl. On Friday, August 2, the U.S. stock markets closed lower, with the Nasdaq Composite entering correction territory. A disappointing jobs report fueled recession fears. Investors reacted negatively, signaling a shift in sentiment where bad economic news is viewed as a genuine concern rather than a potential trigger for Federal Reserve easing In economic data, the Labor Department reported a gain of 114,000 jobs last month, falling short of the 175,000 forecast and the 200,000 needed to match population growth The unemployment rate rose to 4.3%, near a three-year high, heightening concerns about a rapidly slowing economy The Dow Jones Industrial Average was down 1.51% and closed at 39,737.26. The S&P 500 declined 1.84%, ending the day at 5,346.56, and the Nasdaq Composite slid 2.43%, finishing the session at 16,776.16 Read More -------------------------------------------------------------------------------- KEVIN O'LEARY ABOUT KAMALA HARRIS: 'IT'S NOT LIKE SHE JUST STARTED YESTERDAY.' SAYS, 'WHEN YOU VOTE AND GET IT WRONG, I LOSE $50 MILLION' by Adrian Volenik August 4, 2024 11:58 AM | 4 min read | 1 Comment Kevin O’Leary, most known as “Mr. Wonderful” from Shark Tank, recently sat down with Chris Cuomo to share his thoughts on politics and investing in the current climate. In the conversation, O’Leary deeply studied how the political landscape, especially around Kamala Harris, influences his investment decisions. Don't Miss For O’Leary, it’s not about whether you’re a Democrat or a Republican. It's all about the policies that will impact businesses and investments. “I’ve never made any money on politics. I’ve made money on policy,” saying he spent the last three years rubbing shoulders with politicians from all sides of the aisle, not just the red and blue During the interview, O’Leary shared his thoughts on Vice President Kamala Harris and the challenges she faces as a political leader. He was critical of Harris’s past performance and stressed the importance of execution skills in the upcoming election. He said, “There must be another woman of color that has better execution skills [than Harris] … Certainly, there are other women.” “She has a track record. It’s not like she just started yesterday. She’s been here for over three and a half years. It doesn’t matter what a Democrat says. It matters what the independent voter is going to do in the seven states that matter.” Read More -------------------------------------------------------------------------------- Loading... Create a Watchlist FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet. Click to Get Started POPULAR CHANNELS * PreMarket Prep * Press Releases * Analyst Ratings * News * Options * ETFs TOOLS & FEATURES * Real Time Feed * Public RSS Feeds * Submit News Tips * Blog * Embeddable Finance Widgets & Tools * Benzinga Catalyst PARTNERS & CONTRIBUTORS * Affiliate Program * Contributor Portal * Licensing & Syndication * Sponsored Content * Advertise With Us * Lead Generation & SEO ABOUT BENZINGA * About Us * Careers * In The News * Events * Contact Us * Terms & Conditions * Do Not Sell My Personal Data/Privacy Policy * Disclaimer * Service Status * Sitemap © 2024 Benzinga | All Rights Reserved Update Privacy Preferences